Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period:: Alexander Project

被引:61
作者
Mera, RM [1 ]
Miller, LA [1 ]
Daniels, JJD [1 ]
Weil, JG [1 ]
White, AR [1 ]
机构
[1] GlaxoSmithKline, Biomed Data Sci, Res Triangle Pk, NC USA
关键词
Alexander Project; MIC; percent resistance; penicillin; erythromycin;
D O I
10.1016/j.diagmicrobio.2004.10.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Alexander Project is a global surveillance study conducted from 1992 to 2001. Minimum inhibitory concentrations and percent resistance to a panel of antimicrobial agents were determined according to National Committee for Clinical Laboratory Standards methodology. Resistance to penicillin (PEN-R) and erythromycin (ERY-R) have increased in the period 1992-2001 by 3.9 and 4.5 times to 20.7% and 27.9%, respectively. Joint PEN-ERY-R has increased 4.9 times, up to 15.3%. In 1992, 57.1% of all PEN-R isolates were also ERY-R, whereas in 2001, 75.8% were ERY-R. Resistance to only I antibiotic increased slightly, from 8% in 1992 to 12% in 2001, whereas resistance to more than 1 antibiotic increased 4.3 times, from 6.4% in 1992 to 27.8% of all strains in 2001. Multidrug-resistant pneumococci are an increasingly common finding in the United States. Three of four PEN-R isolates are also multiresistant. The rate of growth of multidrug resistance is higher than that of single antibiotic resistance. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 24 条
[1]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[2]   Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence [J].
Ball, P ;
Baquero, F ;
Cars, O ;
File, T ;
Garau, J ;
Klugman, K ;
Low, DE ;
Rubinstein, E ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) :31-40
[3]   Pneumococcal resistance to beta-lactam antibiotics: A global geographic overview [J].
Baquero, F .
MICROBIAL DRUG RESISTANCE, 1995, 1 (02) :115-120
[4]   EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES [J].
BREIMAN, RF ;
BUTLER, JC ;
TENOVER, FC ;
ELLIOTT, JA ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1831-1835
[5]   FAILURE OF CEFOTAXIME IN THE TREATMENT OF MENINGITIS DUE TO RELATIVELY RESISTANT STREPTOCOCCUS-PNEUMONIAE [J].
CATALAN, MJ ;
FERNANDEZ, JM ;
VAZQUEZ, A ;
DESEIJAS, EV ;
SUAREZ, A ;
DEQUIROS, JCLB .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) :766-769
[6]   Antimicrobial susceptibility among communityacquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01 [J].
Doern, GV ;
Brown, SD .
JOURNAL OF INFECTION, 2004, 48 (01) :56-65
[7]   Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States [J].
Doern, GV .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S187-S192
[8]   Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996 [J].
Felmingham, D ;
Washington, J .
JOURNAL OF CHEMOTHERAPY, 1999, 11 :5-21
[9]  
Felmingham D, 1996, J ANTIMICROB CHEMOTH, V38, P1
[10]   Clinical failures: the tip of the iceberg? [J].
Garau, J .
RESPIRATORY MEDICINE, 2001, 95 :S7-S13